More detailed baseline characteristics in each fibrosis stage, including well-known NAFLD-associated genetic variants, such as PNPLA3, TM6SF2, MBOAT7-TMC4, and SREBF-2, are shown in Supplementary Table 4. This evidence concerns the gene SREBF2 and metabolic dysfunction-associated steatotic liver disease.